Aspire Biopharma Holdings, Inc.
ASBPW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire Biopharma Holdings, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $145.4K in total; no superinvestor holds it.
Other share classesASBP
13F holders, Q2 2024
Institutional positions in Aspire Biopharma Holdings, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −1 vs. Q1 2024
- Shares held
- 8.18M
- −676.8K (−7.6%) vs. Q1 2024
- Total value
- $289.3K
- −$10.6K (−3.5%) vs. Q1 2024
- New holders
- 1
- 0 more added
- Sold out
- 2
- 2 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ASBPW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $145.4K |
| Q1 2026 | 31 | $121.7K |
| Q4 2025 | 31 | $142.5K |
| Q3 2025 | 31 | $246.3K |
| Q2 2025 | 31 | $395.1K |
| Q1 2025 | 29 | $639.8K |
| Q4 2024 | 28 | $378.3K |
| Q3 2024 | 32 | $343.1K |
| Q2 2024 | 35 | $289.3K |
| Q1 2024 | 36 | $299.9K |
| Q4 2023 | 37 | $590.3K |
| Q3 2023 | 40 | $494.7K |
| Q2 2023 | 41 | $490.5K |
| Q1 2023 | 36 | $399.0K |
| Q4 2022 | 37 | $627.8K |
| Q3 2022 | 37 | $1.28M |
| Q2 2022 | 37 | $1.38M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Aspire Biopharma Holdings, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Investors Research Corp | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Crossingbridge Advisors, LLC | 166,667 | $0 | 0.00% | +166,667 | New |
| PEAK6 Investments LLC | 12,500 | $375 | 0.00% | 00.0% | Unchanged |
| First Pacific Advisors, LP | 28,482 | $783 | 0.00% | 00.0% | Unchanged |
| Omers Administration Corp | 25,000 | $905 | 0.00% | 00.0% | Unchanged |
| Meteora Capital, LLC | 25,000 | $936 | 0.00% | 00.0% | Unchanged |
| Picton Mahoney Asset Management | 50,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Mint Tower Capital Management B.V. | 25,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,050,000 | $1.05K | 0.00% | 00.0% | Unchanged |
| Walleye Trading LLC | 26,190 | $1.18K | 0.00% | 00.0% | Unchanged |
| Atalaya Capital Management LP | 50,000 | $1.50K | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 46,560 | $2.09K | 0.00% | 00.0% | Unchanged |
| Clear Street LLC | 52,999 | $2.38K | 0.00% | −100−0.2% | Reduced |
| JPMorgan Chase & Co | – | $3.01K | 0.00% | – | – |
| Caas Capital Management LP | 75,000 | $3.37K | 0.01% | 00.0% | Unchanged |
| Exos Asset Management LLC | 137,000 | $4.11K | 0.00% | 00.0% | Unchanged |
| Kim, LLC | 100,000 | $4.49K | 0.00% | 00.0% | Unchanged |
| Nomura Holdings Inc | 150,000 | $4.50K | 0.00% | 00.0% | Unchanged |
| Clear Street Derivatives LLC | 106,000 | $4.76K | 0.00% | 00.0% | Unchanged |
| Flow State Investments, L.P. | 113,498 | $5.10K | 0.00% | 00.0% | Unchanged |
| Whitebox Advisors LLC | 125,000 | $5.61K | 0.00% | 00.0% | Unchanged |
| LMR Partners LLP | 125,000 | $5.61K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 199,999 | $6.02K | 0.00% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 138,536 | $6.22K | 0.00% | 00.0% | Unchanged |
| Taconic Capital Advisors LP | 300,000 | $9.03K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 432,757 | $13.0K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 401,544 | $18.0K | 0.00% | 00.0% | Unchanged |
| Sculptor Capital LP | 500,000 | $18.7K | 0.00% | 00.0% | Unchanged |
| CNH Partners LLC | 647,633 | $19.5K | 0.00% | 00.0% | Unchanged |
| Periscope Capital Inc. | 818,600 | $30.6K | 0.01% | −643,365−44.0% | Reduced |
| Linden Advisors LP | 899,999 | $32.6K | 0.00% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 983,603 | $36.8K | 0.00% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | – | $45.0K | 0.00% | – | – |
| Barclays PLC | 350,000 | – | – | 00.0% | Unchanged |
| Athos Capital Ltd | 21,383 | – | – | 00.0% | Unchanged |
| Context Capital Management, LLC | 0 | $0 | 0.00% | −175,000−100.0% | Sold out |
| EHP Funds Inc. | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |